Antidepressive AgentsFluoxetineSerotonin Uptake InhibitorsAntidepressive Agents, Second-GenerationAntidepressive Agents, TricyclicImipramineAmitriptylineDesipramineDepressive DisorderCitalopramNortriptylineMianserinParoxetineSertralineClomipramineDepressive Disorder, MajorDepressionCyclohexanolsSwimmingAdrenergic Uptake InhibitorsDothiepinMaprotilinePhenelzineFluvoxamineMonoamine Oxidase InhibitorsDepressive Disorder, Treatment-ResistantTrazodoneAnti-Anxiety AgentsSuicidePsychotropic DrugsAmoxapineSerotoninSerotonin Plasma Membrane Transport ProteinsDibenzazepinesPsychiatric Status Rating ScalesHindlimb SuspensionTranylcypromineBehavior, AnimalTrimipramineElectroconvulsive TherapyZimeldineImmobility Response, TonicDrug OverdoseDoxepinBrain-Derived Neurotrophic FactorNorepinephrine Plasma Membrane Transport ProteinsTreatment OutcomeKetamineMoclobemideBupropionAntipsychotic AgentsNeurotransmitter Uptake InhibitorsHypericumReceptor, Serotonin, 5-HT1AHelplessness, LearnedNomifensineDrug InteractionsReceptors, SerotoninDrug PrescriptionsDrug UtilizationAntimanic AgentsPsychotherapyHippocampusBiogenic MonoaminesPlacebo EffectSerotonin AntagonistsMood DisordersBrainTranquilizing AgentsLofepramineMotor ActivityStress, PsychologicalPharmacoepidemiologyRats, Sprague-DawleyBenzodiazepinesAnxiety DisordersElectroshockDrug Utilization ReviewAnxietyCorticosteronePhysician's Practice PatternsTime FactorsBipolar DisorderDose-Response Relationship, DrugReceptors, Serotonin, 5-HT1ImmobilizationSerotonin Receptor AgonistsDrug LabelingRaphe NucleiDrug CostsRandomized Controlled Trials as TopicIprindole